Improving Osteosarcoma Treatment: Comparative Oncology in Action

Improving Osteosarcoma Treatment: Comparative Oncology in Action

Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA, most patients develop recurrent/metastatic disease with a dismally poor outcome. Therapeutic options have not improved for t...

Full description

Bibliographic Details
Main Authors: Lidia Tarone, Katia Mareschi, Elisa Tirtei, Davide Giacobino, Mariateresa Camerino, Paolo Buracco, Emanuela Morello, Federica Cavallo, Federica Riccardo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Life
Subjects:
osteosarcoma
comparative oncology
immunotherapy
CSPG4
Online Access:https://www.mdpi.com/2075-1729/12/12/2099

Internet

https://www.mdpi.com/2075-1729/12/12/2099

Similar Items